Tag: Diabetes
MiniMed expands board to 11 members
June 30, 2026HME News Staff
NORTHRIDGE, Calif. – MiniMed has announced that David Endicott and Linnea Burman have joined its board of directors, expanding the board from nine to 11 members. As MiniMed builds its next chapter as an independent company, Endicott, CEO of Alcon, adds experience scaling global health care businesses, leading through a public market separation and operating at board level in a large, regulated category, the company says. "David has done this before," said Que Dallara, CEO of MiniMed....
Modular Medical announces first patients are using Pivot insulin pump
June 30, 2026HME News Staff
SAN DIEGO – Modular Medical has announced that the first patients have completed onboarding and training and are now actively using the Pivot tubeless insulin patch pump in real-world settings. The company says this milestone marks the transition of the Pivot pump from development into active patient use and represents a significant step in its commercialization strategy. Modular Medical will now begin collecting real world utilization data and user feedback to support broader adoption and...
Modular Medical makes Pivot pump commercially available
June 25, 2026HME News Staff
SAN DIEGO – Modular Medical says its Pivot tubeless insulin patch pump is now commercially available in the U.S., following 510(k) clearance from the U.S. Food and Drug Administration (FDA) in April, marking its transition to a commercial-stage medical device company. The company expects its full commercial launch to roll out in phases, initially targeting select high-volume endocrinology practices and expanding across multiple metropolitan markets by late 2026. "As only the second fully...
MiniMed launches Flex insulin pump in US
June 22, 2026HME News Staff
NORTHRIDGE, Calif. – MiniMed has announced its first commercial launch of the MiniMed Flex system in the United States – the company’s first app-controlled pump and its smallest insulin pump yet. The system launches with Simplera Sync sensor, a disposable, all-in-one sensor with easy two-step insertion. The launch with the Instinct sensor, made by Abbott, will follow later this summer. "For too long, people managing diabetes have had to choose between effective therapy...
In brief: CPAP’s adherence assumption, CGM’s benefits, Shaq’s sleep apnea
June 12, 2026HME News Staff
ORLANDO, Fla. – Many insurers stop covering continuous positive airway pressure (CPAP) devices if patients don’t use them regularly in the first 90 days. But new research presented at the ATS 2026 International Conference shows that many patients who initially struggle to meet these early-use thresholds do go on to use and benefit from CPAP therapy.
The findings challenge long-held assumptions that poor early use predicts long-term CPAP use, said first author Dennis Hwang, MD, a sleep...
Study: CGM use lowers A1C in adults with Type 2 diabetes
June 11, 2026HME News Staff
NEW ORLEANS – Adults with Type 2 diabetes who are on of continuous glucose monitoring (CGM) but who are not on insulin saw substantially reduced hyperglycemia, resulting in a large reduction in A1C compared with a routine care control group, according to new researchers presented at the 2026 Scientific Sessions of the American Diabetes Association (ADA) in New Orleans.
The study found that CGM was associated with a substantial reduction in hyperglycemia, resulting in a 0.9% greater...
Senseonics, Welldoc partner to develop mobile app for Eversense 365
June 10, 2026HME News Staff
GERMANTOWN & COLUMBIA, Md. – Senseonics and Welldoc have announced a strategic partnership to develop a new custom mobile application for the Eversense 365. The next-generation app will maintain all existing features that patients currently benefit from, alongside new features to enhance user experience and facilitate better integration with popular digital health tools. As part of this, the new and improved Eversense 365 app will facilitate seamless integration with Apple Health and Google...
Abbott secures European clearance for dual glucose/ketone device
May 27, 2026HME News Staff
ABBOTT PARK, Ill. – Abbott has secured CE Mark for a dual glucose ketone sensing technology for people with diabetes. Branded as Libre Duo and Libre Duo 10 Day, the systems are designed to continuously measure glucose and ketone levels every minute, providing real-time visibility into both glucose levels needed for daily diabetes management and rising ketones that can lead to a diabetic ketoacidosis (DKA) emergency. The company says this marks the first time people with diabetes will be able...
CCS to present latest research on impact of coaching for CGM users
May 20, 2026HME News Staff
ST. PETERSBURG, Fla. – CCS will offer a poster presentation entitled, “Effect of Structured Coaching and Education on Glycemic and Patient-Reported Outcomes Among Adults Initiating CGM: A Randomized Study” at ISPOR 2026 May 17–20 at the Pennsylvania Convention Center in Philadelphia. The poster showcases soon-to-be-published research highlighting the impact of LivingConnected, a DEAP-accredited program delivering coaching and education for adults starting continuous glucose...
Medtronic’s MiniMed board sees shake up
May 19, 2026HME News Staff
NORTHRIDGE, Calif. – Brett Wall, a class II director of MiniMed Group’s board of directors, has resigned following his departure as executive vice president and president of the neurosciences portfolio of Medtronic, the parent company of MiniMed, according to a Securities and Exchange Commission (SEC) filing. Wall, who was also a member of the board’s Nominating and Corporate Governance Committee, was nominated to the MiniMed board by Medtronic. Scott Cundy will fill his vacancy...